Skip to main content
. 2010 Nov 23;2(1):109–114. doi: 10.3892/ol.2010.211

Table II.

Distribution of positive and negative reactive immunoblot results for anti-OPN antibodies between PCa and non-PCa control groups (BPH and HD).

Immunoblot results for anti-OPN antibodies PCa (n=29) (%) BPH (n=18) (%) HD controls (n=30) (%)
Positive 19/29 (62)a 6/19 (32)b 3/30 (10)
Negative 10/29 (38) 13/19 (68) 27/30 (90)
Total 29 18 30
a

P (χ2≥3.67)=0.0554 compared to BPH and P (χ2≥17.59)=0.00003 compared to HD controls.

b

P (χ2≥17.59)=0.00015 compared to HD controls.

BPH, benign prostate hyperplasia; HD, healthy male donors; PCa, prostate cancer.